Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Aberrant Crypt Foci
B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.
Abortion, Spontaneous
Alpha-fetoprotein (AFP) levels in maternal serum in 115 patients with spontaneous abortion.
Abortion, Spontaneous
Alpha-fetoprotein levels in amniotic fluids from spontaneous abortions.
Abortion, Spontaneous
Maternal serum alpha-fetoprotein and spontaneous abortion.
Abortion, Threatened
Alpha-fetoprotein: a marker for threatened abortion.
Abortion, Threatened
Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
Abortion, Threatened
[Changes in the blood level of alpha-fetoprotein in threatened abortion]
Abruptio Placentae
Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Abruptio Placentae
Maternal serum alpha-fetoprotein in placental abruption associated with preterm labor.
Acidosis
Hypercapnic acidosis confers antioxidant and anti-apoptosis effects against ventilator-induced lung injury.
Acidosis, Lactic
[Giant placental angioma with polyhydramnios, high level of alpha-fetoprotein and neonatal congenital lactic acidosis]
Acute Kidney Injury
Important role of apoptosis signal-regulating kinase 1 in ischemic acute kidney injury.
Acute Kidney Injury
Necroptosis in 3-chloro-1, 2-propanediol (3-MCPD)-dipalmitate-induced acute kidney injury in vivo and its repression by miR-223-3p.
Acute Lung Injury
Mitogen-activated protein kinase kinase kinase 1 protects against nickel-induced acute lung injury.
Acute Lung Injury
SOCS-1 rescues IL-1?-mediated suppression of epithelial sodium channel in mouse lung epithelial cells via ASK-1.
Acute-On-Chronic Liver Failure
Alpha-Fetoprotein as a Predictive Marker for Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure.
acyl-coa dehydrogenase deficiency
Prenatal diagnosis of multiple acyl-CoA dehydrogenase deficiency: association with elevated alpha-fetoprotein and cystic renal changes.
Adenocarcinoma
A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman.
Adenocarcinoma
A study on the lectin reactivity of alpha-fetoprotein produced by hepatoid adenocarcinomas and yolk sac tumors.
Adenocarcinoma
Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
Adenocarcinoma
Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C.
Adenocarcinoma
Alpha-fetoprotein and carbohydrate antigen 19-9 producing advanced adenocarcinoma of renal pelvis and ureter.
Adenocarcinoma
Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin.
Adenocarcinoma
Alpha-fetoprotein producing Barrett's esophageal adenocarcinoma: a case report.
Adenocarcinoma
Alpha-fetoprotein producing endometrial adenocarcinoma: report of a case.
Adenocarcinoma
Alpha-Fetoprotein Producing Gastric Adenocarcinoma in an Elderly Adult.
Adenocarcinoma
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Adenocarcinoma
Alpha-fetoprotein production by a hepatoid adenocarcinoma of the uterus.
Adenocarcinoma
Apoptosis Signal-Regulating Kinase 1 (ASK1) Activation is Involved in Silver Nanoparticles Induced Apoptosis of A549 Lung Cancer Cell Line.
Adenocarcinoma
Association of Breast Cancer Susceptibility Variants with Risk of Pancreatic Cancer.
Adenocarcinoma
Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.
Adenocarcinoma
Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine endometrial adenocarcinoma.
Adenocarcinoma
Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.
Adenocarcinoma
Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor.
Adenocarcinoma
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas.
Adenocarcinoma
Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells.
Adenocarcinoma
Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Adenocarcinoma
Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.
Adenocarcinoma
Differentially expressed genes associated with mouse lung tumor progression.
Adenocarcinoma
Education and Imaging. Gastrointestinal: brain metastasis of alpha-fetoprotein producing gastric adenocarcinoma.
Adenocarcinoma
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Adenocarcinoma
ERK/pERK expression, B-raf and K-ras mutations in colon adenocarcinomas: correlation with clinicopathological characteristics and expression of hMLH1 and hMSH2.
Adenocarcinoma
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Adenocarcinoma
Extremely high expression of serum alpha-fetoprotein level of gastric adenocarcinoma: a rare case with an unexpected well-prognosis.
Adenocarcinoma
Hepatoid adenocarcinoma of the endometrium associated with alpha-fetoprotein production.
Adenocarcinoma
Hepatoid adenocarcinoma of the gallbladder with production of alpha-fetoprotein.
Adenocarcinoma
Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment.
Adenocarcinoma
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Adenocarcinoma
Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
Adenocarcinoma
Increased alpha-fetoprotein concentration in association with ileal adenocarcinoma complicating Crohn's disease.
Adenocarcinoma
Laricitrin suppresses increased benzo(a)pyrene-induced lung tumor-associated monocyte-derived dendritic cell cancer progression.
Adenocarcinoma
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.
Adenocarcinoma
Molecular diagnostic testing as an adjunct to morphologic evaluation of pancreatic ductal system brushings: potential augmentation for diagnostic sensitivity.
Adenocarcinoma
Molecular pathology of lung cancer: current status and perspectives.
Adenocarcinoma
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Adenocarcinoma
Overexpression of MEKK2 is associated with colorectal carcinogenesis.
Adenocarcinoma
Permanent conversion of NIH3T3 cells transformed by activated c-Ha-ras, c-Ki-ras, N-ras, or c-raf, and of human pancreatic adenocarcinoma containing activated c-Ki-ras to apparently normal cells by treatment with the antibiotic azatyrosine.
Adenocarcinoma
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
Adenocarcinoma
Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression.
Adenocarcinoma
Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma.
Adenocarcinoma
Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration.
Adenocarcinoma
Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor.
Adenocarcinoma
Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization.
Adenocarcinoma
Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Adenocarcinoma
The adenocarcinoma cell surface mucin receptor for alpha-fetoprotein: is the same receptor present on circulating monocytes and macrophages? A commentary.
Adenocarcinoma
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases.
Adenocarcinoma
The role of MEKK1 in hypertrophic cardiomyopathy.
Adenocarcinoma
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Adenocarcinoma
[Ap1-like cis-elements in 5'-regulatory region of human apolipoprotein A-I gene]
Adenocarcinoma
[Hepatoid adenocarcinoma of the lung with negative alpha-fetoprotein: a case report].
Adenocarcinoma
[Ovarian serous adenocarcinoma with functioning stroma and production of estrogen and alpha-fetoprotein]
Adenocarcinoma of Lung
A cross-platform comparison of affymetrix and Agilent microarrays reveals discordant miRNA expression in lung tumors of c-Raf transgenic mice.
Adenocarcinoma of Lung
A Cross-Platform Comparison of Genome-Wide Expression Changes of Laser Microdissected Lung Tissue of C-Raf Transgenic Mice Using 3'IVT and Exon Array.
Adenocarcinoma of Lung
Apoptosis signal-regulating kinase 1 mediates denbinobin-induced apoptosis in human lung adenocarcinoma cells.
Adenocarcinoma of Lung
c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.
Adenocarcinoma of Lung
Incidence of Lung Adenocarcinoma Biomarker in a Caribbean and African Caribbean Population.
Adenocarcinoma of Lung
Molecular alterations in non-small cell lung carcinomas of the young.
Adenocarcinoma of Lung
Multiplex Diagnosis of Oncogenic Fusion and MET Exon Skipping by Molecular Counting Using Formalin-Fixed Paraffin Embedded Lung Adenocarcinoma Tissues.
Adenocarcinoma of Lung
Receptor tyrosine kinase-like orphan receptor 1, a target of NKX2-1/TTF-1 lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma.
Adenocarcinoma of Lung
Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers.
Adenocarcinoma, Clear Cell
Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Adenoma
B-RAF mutations are a rare event in pituitary adenomas.
Adenoma
BAG-1 haplo-insufficiency impairs lung tumorigenesis.
Adenoma
Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1.
Adenoma
Differentially expressed genes associated with mouse lung tumor progression.
Adenoma
Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth.
Adenoma
Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.
Adenoma
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Adenoma
No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations.
Adenoma
Overexpression of MEKK2 is associated with colorectal carcinogenesis.
Adenoma
Uptake of radiolabelled alpha-fetoprotein by experimental mammary adenocarcinoma and adenoma: in vivo and in vitro studies.
Adenoma
Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Adenoma
Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structure.
Adenoma
Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.
Adenoma
[The RAS paradoxon of the EGFR-targeted therapy of colorectal cancer]
Adenoma, Bile Duct
Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Adenoma, Bile Duct
Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.
Adenoma, Islet Cell
Alpha-fetoprotein associated with islet cell tumors.
Adenoma, Liver Cell
Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats.
Adenoma, Pleomorphic
No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations.
Adenoma, Pleomorphic
Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12.
Adenomatous Polyposis Coli
Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
Adenomatous Polyposis Coli
Differential molecular assemblies underlie the dual function of Axin in modulating the WNT and JNK pathways.
Adenomatous Polyposis Coli
Long-fragment DNA as a potential marker for stool-based detection of colorectal cancer.
Adenoviridae Infections
Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription.
Adrenocortical Carcinoma
Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma - Long survival with various therapeutic strategies including a lung resection: Report of a case.
Alopecia
Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency.
Amniotic Band Syndrome
A stillborn fetus with amniotic band syndrome and elevated levels of alpha-fetoprotein plus beta-human chorionic gonadotropin: a case report.
Anemia
Maternal serum alpha-fetoprotein, fetal middle cerebral artery blood flow velocity and fetal haemoglobin in pregnancies at risk of fetal anaemia.
Anencephaly
Alpha-fetoprotein in anencephaly.
Anencephaly
Alpha-fetoprotein in antenatal diagnosis of anencephaly and spina bifida.
Anencephaly
Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.
Anencephaly
Alpha-fetoprotein levels in amniotic fluid in normal pregnancy and in pregnancy complicated by anencephaly.
Anencephaly
Amniotic fluid alpha-fetoprotein in anencephaly.
Anencephaly
Amniotic fluid alpha-fetoprotein levels in anencephaly and open spina bifida: validation of median cut-off limits.
Anencephaly
Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Anencephaly
Biamnial elevated alpha-fetoprotein and positive acetylcholinesterase in twins, one with anencephaly.
Anencephaly
Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
Anencephaly
Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly.
Anencephaly
Letter: amniotic alpha-fetoprotein levels and anencephaly.
Anencephaly
Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Anencephaly
The molecular nature of alpha-fetoprotein in anencephaly and spina bifida.
Anencephaly
[Prenatal diagnosis of anencephaly and open spina bifida by combined use of amniotic or maternal serum alpha-fetoprotein and maternal urine estrogen/creatinine ratio (author's transl)]
Angelman Syndrome
Alpha-fetoprotein in Angelman syndrome.
Angiomyolipoma
The role of tuberin in cellular differentiation: are B-raf and MAPK involved?
Anthrax
Cytotoxicity of the matrix metalloproteinase-activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells.
Anthrax
Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.
Anus, Imperforate
Maternal serum alpha-fetoprotein and anal atresia.
Anus, Imperforate
Maternal serum alpha-fetoprotein in fetal anal atresia and other gastro-intestinal obstructions.
Apraxias
Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Apraxias
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
aromatase deficiency
Molecular diagnostics of disorders of sexual development: an Indian survey and systems biology perspective.
Arteriovenous Fistula
Combined use of alpha-fetoprotein and ultrasound in the prenatal diagnosis of arteriovenous fistula in the brain.
Arthralgia
Intermittent B-Raf inhibitor therapy is a feasible option -report of a patient with metastatic melanoma.
Arthritis
Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis.
Arthritis
Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Arthritis
Suppression of experimental antigen-induced arthritis in transgenic mice producing human alpha-fetoprotein.
Arthritis
The effect of apoptosis signal-regulating kinase 1 gene transfer on rat collagen induced arthritis.
Arthritis, Experimental
Necrostatin-1 ameliorates adjuvant arthritis rat articular chondrocyte injury via inhibiting ASIC1a-mediated necroptosis.
Arthritis, Rheumatoid
A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis.
Arthritis, Rheumatoid
Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis.
Arthritis, Rheumatoid
Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.
Arthritis, Rheumatoid
Elevated serum alpha-fetoprotein in a pregnant woman with rheumatoid arthritis.
Arthritis, Rheumatoid
Gene-gene interaction and RNA splicing profiles of MAP2K4 gene in rheumatoid arthritis.
Arthritis, Rheumatoid
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients.
Arthritis, Rheumatoid
K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis.
Arthritis, Rheumatoid
MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes.
Arthritis, Rheumatoid
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Arthritis, Rheumatoid
Regulation and function of apoptosis signal-regulating kinase 1 in rheumatoid arthritis.
Arthritis, Rheumatoid
Regulation and function of TPL-2, an I?B kinase-regulated MAP kinase kinase kinase.
Arthritis, Rheumatoid
Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes.
Asthma
Biochemical studies of N-methyltransferase in human and guinea-pig lung: no apparent role in the pathogenesis of asthma.
Asthma
No association of histamine- N-methyltransferase polymorphism with asthma or bronchial hyperresponsiveness in two German pediatric populations.
Astrocytoma
Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: association with activation of ERK and AKT.
Astrocytoma
BRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma.
Astrocytoma
Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
Astrocytoma
Differential effects of cAMP in neurons and astrocytes. Role of B-raf.
Astrocytoma
Genetic recombination in human melanoma and astrocytoma cell lines involves oncogenes and growth factor genes.
Ataxia
Alpha-fetoprotein as a biomarker for recessive ataxias.
Ataxia
Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
Ataxia
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Ataxia
Cytogenetic anomalies in a patient with ataxia, immune deficiency, and high alpha-fetoprotein in the absence of telangiectasia.
Ataxia Telangiectasia
Alpha-fetoprotein in serum and amniotic fluid in the diagnosis of neonatal hepatitis syndrome, Indian childhood cirrhosis, cystic fibrosis, ataxia telangiectasia and spina bifida.
Ataxia Telangiectasia
Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver.
Ataxia Telangiectasia
Racial Disparities in the Molecular Landscape of Cancer.
Ataxia Telangiectasia
Tissue of origin of elevated alpha-fetoprotein in ataxia-telangiectasia.
Atherosclerosis
A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1.
Atherosclerosis
A20 functions as mediator in TNF?-induced injury of human umbilical vein endothelial cells through TAK1-dependent MAPK/eNOS pathway.
Atherosclerosis
Critical and diverse in vivo roles of apoptosis signal-regulating kinase 1 in animal models of atherosclerosis and cholestatic liver injury.
Atherosclerosis
Endothelial MAP4K4 is critical for lymphatic vascular development and function.
Atherosclerosis
Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques.
Atherosclerosis
Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.
Atherosclerosis
Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity.
Autoimmune Diseases
A role of alpha-fetoprotein in autoimmune diseases.
Autoimmune Diseases
Alpha-fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases.
Autoimmune Diseases
MM-093, a recombinant human alpha-fetoprotein for the potential treatment of rheumatoid arthritis and other autoimmune diseases.
Autoimmune Diseases
The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.
Bacterial Infections
MEKK3 Regulates IFN-{gamma} Production in T Cells through the Rac1/2-Dependent MAPK Cascades.
Beckwith-Wiedemann Syndrome
Alpha-fetoprotein in Wiedemann-Beckwith syndrome.
Beckwith-Wiedemann Syndrome
Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels.
Beckwith-Wiedemann Syndrome
Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome.
Beckwith-Wiedemann Syndrome
Serum alpha-fetoprotein screening for hepatoblastoma in Beckwith-Wiedemann syndrome.
Beckwith-Wiedemann Syndrome
Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia.
Beckwith-Wiedemann Syndrome
The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.
Biliary Atresia
Serum alpha-fetoprotein levels in extrahepatic biliary atresia, idiopathic neonatal hepatitis and alpha-1-antitrypsin deficiency (PiZ).
Biliary Atresia
The role of alpha-fetoprotein in the differentiation of neonatal hepatitis and biliary atresia.
Bowen's Disease
Human alpha-fetoprotein in the epidermal cells of Bowen's disease.
Brain Infarction
Regulation of Microglia and Macrophage Polarization via Apoptosis Signal-Regulating Kinase 1 Silencing after Ischemic/Hypoxic Injury.
Brain Injuries
Apoptosis signal-regulating kinase 1 (ASK1) is linked to neural stem cell differentiation after ischemic brain injury.
Brain Injuries
Dual inhibitory roles of geldanamycin on the c-Jun NH(2)-terminal kinase 3 signal pathway through suppressing the expression of mixed-lineage kinase 3 and attenuating the activation of apoptosis signal-regulating kinase 1 via facilitating the activation of Akt in ischemic brain injury.
Brain Injuries
Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation.
Brain Injuries
The degradation of mixed lineage kinase domain-like protein promotes neuroprotection after ischemic brain injury.
Brain Injuries, Traumatic
Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats.
Brain Ischemia
Activation and autophosphorylation of apoptosis signal-regulating kinase 1 (ASK1) following cerebral ischemia in rat hippocampus.
Brain Ischemia
Antioxidant N-acetylcysteine inhibits the activation of JNK3 mediated by the GluR6-PSD95-MLK3 signaling module during cerebral ischemia in rat hippocampus.
Brain Ischemia
Biphasic activation of apoptosis signal-regulating kinase 1-stress-activated protein kinase 1-c-Jun N-terminal protein kinase pathway is selectively mediated by Ca2+-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors involving oxidative stress following brain ischemia in rat hippocampus.
Brain Ischemia
Blockade of Apoptosis Signal-Regulating Kinase 1 Attenuates Matrix Metalloproteinase 9 Activity in Brain Endothelial Cells and the Subsequent Apoptosis in Neurons after Ischemic Injury.
Brain Ischemia
Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury.
Brain Ischemia
Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1.
Brain Ischemia
Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential.
Brain Ischemia
Regulation of Microglia and Macrophage Polarization via Apoptosis Signal-Regulating Kinase 1 Silencing after Ischemic/Hypoxic Injury.
Brain Ischemia
S-nitrosylation of mixed lineage kinase 3 contributes to its activation after cerebral ischemia.
Brain Neoplasms
JSAP1/JIP3 cooperates with focal adhesion kinase to regulate c-Jun N-terminal kinase and cell migration.
Brain Neoplasms
PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.
Breast Neoplasms
A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
Breast Neoplasms
A MAP3k1 SNP predicts survival of gastric cancer in a Chinese population.
Breast Neoplasms
A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells.
Breast Neoplasms
A single point mutation responsible for c-mos polymorphism in cancer patients.
Breast Neoplasms
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
Breast Neoplasms
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
Breast Neoplasms
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Breast Neoplasms
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence.
Breast Neoplasms
Alpha-fetoprotein receptors in a human breast cancer cell line.
Breast Neoplasms
Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Breast Neoplasms
Apoptosis signal-regulating kinase 1 is associated with the effect of claudin-6 in breast cancer.
Breast Neoplasms
Association between Mitogen-Activated Protein Kinase Kinase Kinase 1 Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis of 20 Case-Control Studies.
Breast Neoplasms
Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Breast Neoplasms
Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Breast Neoplasms
B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
Breast Neoplasms
Beyond the twinning effect: invited commentary on "Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk".
Breast Neoplasms
Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Breast Neoplasms
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3.
Breast Neoplasms
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.
Breast Neoplasms
Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
Breast Neoplasms
Breast cancer susceptibility variants alter risks in familial disease.
Breast Neoplasms
Breast cancer susceptibility: current knowledge and implications for genetic counselling.
Breast Neoplasms
c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Breast Neoplasms
Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers.
Breast Neoplasms
CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome.
Breast Neoplasms
Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Breast Neoplasms
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Breast Neoplasms
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast Neoplasms
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
Breast Neoplasms
Detection and measurement of alpha-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride.
Breast Neoplasms
Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Breast Neoplasms
Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women.
Breast Neoplasms
Dominant-negative Jun N-terminal protein kinase (JNK-1) inhibits metabolic oxidative stress during glucose deprivation in a human breast carcinoma cell line.
Breast Neoplasms
Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.
Breast Neoplasms
Estrogen receptor and alpha-fetoprotein in human breast cancer: brief communication.
Breast Neoplasms
Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.
Breast Neoplasms
Expression of apoptosis signal-regulating kinase 1 is associated with tight junction protein claudin-6 in cervical carcinoma.
Breast Neoplasms
Expression of the alpha-fetoprotein gene in human breast cancer.
Breast Neoplasms
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Breast Neoplasms
Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer.
Breast Neoplasms
Genetic susceptibility loci for breast cancer by estrogen receptor status.
Breast Neoplasms
Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Breast Neoplasms
Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Breast Neoplasms
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Breast Neoplasms
Hormone-related pathways and risk of breast cancer subtypes in African American women.
Breast Neoplasms
Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Breast Neoplasms
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
Breast Neoplasms
Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
Breast Neoplasms
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
Breast Neoplasms
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk.
Breast Neoplasms
IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.
Breast Neoplasms
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.
Breast Neoplasms
Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
Breast Neoplasms
Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Breast Neoplasms
Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis.
Breast Neoplasms
JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer.
Breast Neoplasms
JARID1B is a luminal lineage-driving oncogene in breast cancer.
Breast Neoplasms
Knockdown of apoptosis signal-regulating kinase 1 modulates basal glycogen synthase kinase-3? kinase activity and regulates cell migration.
Breast Neoplasms
Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk.
Breast Neoplasms
Mammary tumor development in dogs is associated with BRCA1 and BRCA2.
Breast Neoplasms
MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro.
Breast Neoplasms
MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis.
Breast Neoplasms
Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Breast Neoplasms
MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Breast Neoplasms
MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
Breast Neoplasms
MEKK1/JNK signaling stabilizes and activates p53.
Breast Neoplasms
MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells.
Breast Neoplasms
MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells.
Breast Neoplasms
MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer.
Breast Neoplasms
MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
Breast Neoplasms
Non-Benzoquinone Geldanamycin Analog, WK-88-1, Induces Apoptosis in Human Breast Cancer Cell Lines.
Breast Neoplasms
Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
Breast Neoplasms
Overexpression of the Tpl-2/Cot oncogene in human breast cancer.
Breast Neoplasms
Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.
Breast Neoplasms
Pharmacologic inhibition of MLK3 kinase activity blocks the in vitro migratory capacity of breast cancer cells but has no effect on breast cancer brain metastasis in a mouse xenograft model.
Breast Neoplasms
Platycodin d induces reactive oxygen species-mediated apoptosis signal-regulating kinase 1 activation and endoplasmic reticulum stress response in human breast cancer cells.
Breast Neoplasms
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
Breast Neoplasms
Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
Breast Neoplasms
Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Breast Neoplasms
Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.
Breast Neoplasms
Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Breast Neoplasms
Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.
Breast Neoplasms
RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors.
Breast Neoplasms
RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-?B.
Breast Neoplasms
Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Breast Neoplasms
Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells.
Breast Neoplasms
Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth.
Breast Neoplasms
Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.
Breast Neoplasms
Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
Breast Neoplasms
T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients.
Breast Neoplasms
The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells.
Breast Neoplasms
Topological alternate centrality measure capturing drug targets in the network of MAPK pathways.
Breast Neoplasms
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis.
Breast Neoplasms
Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2.
Breast Neoplasms
Variations of serum carcinoembryonic antigen, alpha-fetoprotein and immunoglobulin levels in patients with breast cancer.
Breast Neoplasms
Vimentin and alpha-fetoprotein expression in breast cancer smears: relationship with various prognostic factors.
Breast Neoplasms
[Genetic polymorphism and susceptibility to cancer]
Breast Neoplasms
[Implications of genetic risk factors in breast cancer: culprit genes and associated malignancies]
Burkitt Lymphoma
c-Ha-ras1 is not deleted in aniridia-Wilms' tumour association.
Carcinogenesis
A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
Carcinogenesis
A novel role for mixed-lineage kinase-like mitogen-activated protein triple kinase alpha in neoplastic cell transformation and tumor development.
Carcinogenesis
A RING to rule them all? Insights into the Map3k1 PHD motif provide a new mechanistic understanding into the diverse roles of Map3k1.
Carcinogenesis
Alpha-fetoprotein (AFP) and alpha 2-macroglobulin (alpha 2-M) as the markers of distinct responses of hepatocytes to carcinogens in the rat: carcinogenesis.
Carcinogenesis
alpha-Fetoprotein and albumin genes of rats: no evidence for amplification-deletion or rearrangement in rat liver carcinogenesis.
Carcinogenesis
alpha-Fetoprotein and albumin mRNA levels in liver regeneration and carcinogenesis.
Carcinogenesis
alpha-Fetoprotein levels and hepatic alterations during chemical carcinogenesis in C57BL/6N mice.
Carcinogenesis
Alpha-fetoprotein molecular heterogeneity. Physiologic correlations with normal growth, carcinogenesis and tumor growth.
Carcinogenesis
Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer.
Carcinogenesis
Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses.
Carcinogenesis
B-Raf inhibitors induce epithelial differentiation in BRAF-mutant colorectal cancer cells.
Carcinogenesis
B-Raf is dispensable for K-Ras-mediated oncogenesis in human cancer cells.
Carcinogenesis
B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.
Carcinogenesis
B-RAF mutations are a rare event in pituitary adenomas.
Carcinogenesis
C-raf expression in early rat liver tumorigenesis after promotion with polychlorinated biphenyls or phenobarbital.
Carcinogenesis
C-Raf is required for the initiation of lung cancer by K-Ras.
Carcinogenesis
Cell lineages in liver carcinogenesis: possible clues from studies of the distribution of alpha-fetoprotein RNA sequences in cell populations isolated from normal, regenerating, and preneoplastic rat livers.
Carcinogenesis
Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression.
Carcinogenesis
Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Carcinogenesis
Differential roles of ASK1 and TAK1 in Helicobacter pylori-induced cellular responses.
Carcinogenesis
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.
Carcinogenesis
Elimination of B-RAF in oncogenic C-RAF-expressing alveolar epithelial type II cells reduces MAPK signal intensity and lung tumor growth.
Carcinogenesis
Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.
Carcinogenesis
Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development.
Carcinogenesis
Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis.
Carcinogenesis
Expression of B-RAF V600E in type II pneumocytes causes abnormalities in alveolar formation, airspace enlargement and tumor formation in mice.
Carcinogenesis
Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis.
Carcinogenesis
Functional analysis of mutations within the kinase activation segment of B-Raf in human colorectal tumors.
Carcinogenesis
Genomic organization and expression of Tpl-2 in normal cells and Moloney murine leukemia virus-induced rat T-cell lymphomas: activation by provirus insertion.
Carcinogenesis
HCC Specific Protein Network Involving Interactions of EGFR with A-Raf and Transthyretin: Experimental Analysis and Computational Biology Correlates.
Carcinogenesis
hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation.
Carcinogenesis
Identification, by cDNA microarray, of A-raf and proliferating cell nuclear antigen as genes induced in rat lung by exposure to diesel exhaust.
Carcinogenesis
Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG12D/Pdx-1-Cre Mice.
Carcinogenesis
Inhibition of mutant Kras(G12D)-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
Carcinogenesis
Lin9, a subunit of the mammalian DREAM complex, is essential for embryonic development, for survival of adult mice and for tumor suppression.
Carcinogenesis
Loss of BRCA1 Spontaneously Induces the Tumorigenesis in Lacrimal Gland.
Carcinogenesis
Mammary cancer promotion and MAPK activation associated with consumption of a corn oil-based high-fat diet.
Carcinogenesis
Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
Carcinogenesis
Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression.
Carcinogenesis
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.
Carcinogenesis
Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
Carcinogenesis
Mixed Lineage Kinase MLK4 Is Activated in Colorectal Cancers Where It Synergistically Cooperates with Activated RAS Signaling in Driving Tumorigenesis.
Carcinogenesis
Molecular alterations in non-small cell lung carcinomas of the young.
Carcinogenesis
Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.
Carcinogenesis
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
Carcinogenesis
On the synthesis of alpha-fetoprotein during liver carcinogenesis by N-2-fluorenylacetamide and its relationships with the intracellular localization of the carcinogen.
Carcinogenesis
Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation.
Carcinogenesis
Oncogenic B-Raf(V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells.
Carcinogenesis
Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling.
Carcinogenesis
Overexpression of MEKK2 is associated with colorectal carcinogenesis.
Carcinogenesis
p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner.
Carcinogenesis
RAF expression in human astrocytic tumors.
Carcinogenesis
RanBPM is an inhibitor of ERK signaling.
Carcinogenesis
RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
Carcinogenesis
Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.
Carcinogenesis
Relationship between alpha-fetoprotein positive cells and precancerous lesions in rat liver during 3'-methyl-4-dimethylaminoazobenzene carcinogenesis.
Carcinogenesis
Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas.
Carcinogenesis
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Carcinogenesis
Revealing A-Raf functions through its interactome.
Carcinogenesis
Sequence content of alpha-fetoprotein, albumin and fibrinogen polypeptide mRNAs in different organs, developing tissues and in liver during carcinogenesis in rats.
Carcinogenesis
Skin tumorigenesis stimulated by Raf inhibitors relies upon Raf functions that are dependent and independent of ERK.
Carcinogenesis
SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.
Carcinogenesis
Structural investigation of B-raf paradox breaker and inducer inhibitors.
Carcinogenesis
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.
Carcinogenesis
Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications.
Carcinogenesis
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.
Carcinogenesis
The BRAF mutation is associated with the prognosis in colorectal cancer.
Carcinogenesis
The expression of alpha-fetoprotein and albumin genes in rat liver during chemical carcinogenesis.
Carcinogenesis
The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
Carcinogenesis
The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines.
Carcinogenesis
Tpl-2 kinase downregulates the activity of p53 and enhances signaling pathways leading to activation of activator protein 1 induced by EGF.
Carcinogenesis
Tumorigenesis suppressor pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
Carcinogenesis
[Characteristics of alpha-fetoprotein synthesis in the early stages of hepatic carcinogenesis in mice with a various sensitivity to ortho-aminoazotoluene]
Carcinogenesis
[CNC proteins in physiology and pathology].
Carcinogenesis
[DAB carcinogenesis in rats and fluctuation of alpha-fetoprotein]
Carcinogenesis
[Possibilities for the spread of alpha-fetoprotein and heterologous antibodies in mother and fetus during transplacental carcinogenesis]
Carcinogenesis
[Serous genital carcinoma : Molecular pathogenesis and the role of tubal fimbria.]
Carcinogenesis
[The RAS paradoxon of the EGFR-targeted therapy of colorectal cancer]
Carcinogenesis
[Transitory cell antigens of rat liver. 3. The reappearance of alpha-fetoprotein during chemical carcinogenesis (author's transl)]
Carcinoid Tumor
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target.
Carcinoma
A case of gallbladder carcinoma producing both alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA).
Carcinoma
A case of gastric carcinoma whose serum was positive for alpha-fetoprotein, variant alkaline phosphatase and CEA (author's transl)]
Carcinoma
A primary lung carcinoma producing alpha-fetoprotein, carcinoembryonic antigen, and human chorionic gonadotropin. Immunohistochemical and biochemical studies.
Carcinoma
A single point mutation responsible for c-mos polymorphism in cancer patients.
Carcinoma
Abrogation of c-Raf expression induces apoptosis in tumor cells.
Carcinoma
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.
Carcinoma
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.
Carcinoma
Activation of an alpha-fetoprotein (AFP)/receptor autocrine loop in HT-29 human colon carcinoma cells.
Carcinoma
Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B-Raf gene mutations.
Carcinoma
Adenoendocrine cell carcinoma of the gallbladder producing a high level of alpha-fetoprotein.
Carcinoma
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.
Carcinoma
Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?
Carcinoma
Alpha-fetoprotein and carcinoembryonic antigen in a case of gastric carcinoma metastatic to the liver.
Carcinoma
Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
Carcinoma
Alpha-fetoprotein and gastric carcinoma.
Carcinoma
Alpha-fetoprotein elevation in NUT midline carcinoma: a case report.
Carcinoma
Alpha-fetoprotein in a patient with embryonal cell carcinoma of the testes.
Carcinoma
Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver.
Carcinoma
Alpha-fetoprotein in patients of gastric carcinoma with or without liver metastasis.
Carcinoma
Alpha-fetoprotein producing carcinoma of the gallbladder associated with anomalous arrangement of the pancreaticobiliary ductal system--early detection through an attack of acute pancreatitis.
Carcinoma
alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes.
Carcinoma
Alpha-fetoprotein producing mucin-producing carcinoma of the pancreas: a case report with immunohistochemical study and lectin-affinity profile.
Carcinoma
Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: A case report.
Carcinoma
Alpha-fetoprotein producing renal cell carcinoma: a case report.
Carcinoma
Alpha-fetoprotein producing undifferentiated carcinoma of the bladder.
Carcinoma
Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Carcinoma
Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor.
Carcinoma
Analysis of lectin affinity immunoelectrophoretic profiles of serum alpha-fetoprotein from patients with yolk sac tumors and carcinomas of the gastrointestinal tract: correlations with molecular structures.
Carcinoma
Analysis of the anatomic subsites, gender and age in unresectable advanced colorectal carcinomas in Tochigi, Japan suggests a shift in location towards the right side colon in elderly patients treated with cetuximab.
Carcinoma
Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
Carcinoma
Anti-Cytokeratin CAM 5.2 (Becton Dickinson) is not synonymous with CK8/18 monoclonal antibody. Comment on "Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 42:167-174".
Carcinoma
Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells.
Carcinoma
ASK1 mediates apoptotic cell death induced by genotoxic stress.
Carcinoma
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
Carcinoma
B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome.
Carcinoma
B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.
Carcinoma
B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas.
Carcinoma
Brain metastases and elevated alpha-fetoprotein level in a patient with esophageal carcinoma.
Carcinoma
c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
Carcinoma
c-mos immunoreactivity is an indicator of good prognosis in lung cancer.
Carcinoma
c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma.
Carcinoma
Cancer emerging from the recurrence of sessile serrated adenoma/polyp resected endoscopically 5 years ago.
Carcinoma
Carcinoembryonic antigen, alpha-fetoprotein and carcinoplacental alkaline phosphatase in gastric carcinoma metastatic to the liver.
Carcinoma
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.
Carcinoma
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Carcinoma
Collecting duct carcinoma of kidney producing alpha-fetoprotein.
Carcinoma
Computational study on the unbinding pathways of B-RAF inhibitors and its implication for the difference of residence time: insight from random acceleration and steered molecular dynamics simulations.
Carcinoma
Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression.
Carcinoma
Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth.
Carcinoma
Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.
Carcinoma
Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.
Carcinoma
Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Carcinoma
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Carcinoma
Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
Carcinoma
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.
Carcinoma
Distinctions between clinicopathological factors and prognosis of alpha-fetoprotein negative and positive hepatocelluar carcinoma patients.
Carcinoma
Downregulation of survivin and aurora a by histone deacetylase and RAS inhibitors: A new drug combination for cancer therapy.
Carcinoma
Editoral: Alpha-fetoprotein in primary carcinoma of the liver and other diseases.
Carcinoma
Elevated serum alpha-fetoprotein in a patient with undifferentiated carcinoma of the gall bladder.
Carcinoma
Elevated serum alpha-fetoprotein levels in primary gallbladder carcinoma without hepatic involvement.
Carcinoma
Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.
Carcinoma
Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
Carcinoma
Establishment and characterization of HEPFT, a cell line derived from hepatoid carcinoma of the fallopian tube, with special reference to alpha-fetoprotein, lectin affinity and histogenesis.
Carcinoma
Establishment of a testicular carcinoma cell line producing alpha-fetoprotein.
Carcinoma
Evaluation of N-acetylneuraminic acid, carcinoembryonic antigen, and alpha-fetoprotein as markers for advanced carcinoma.
Carcinoma
Expression and prognostic role of MEKK3 and pERK in patients with renal clear cell carcinoma.
Carcinoma
Expression of apoptosis signal-regulating kinase 1 is associated with tight junction protein claudin-6 in cervical carcinoma.
Carcinoma
Expression of polysialic acid in primary laryngeal squamous cell carcinoma.
Carcinoma
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Carcinoma
Expression of ssDNA in mammalian cells.
Carcinoma
Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
Carcinoma
Fas-induced apoptosis of renal cell carcinoma is mediated by apoptosis signal-regulating kinase 1 via mitochondrial damage-dependent caspase-8 activation.
Carcinoma
Ferritin, alpha-fetoprotein and carcinoembryonic antigen concentration in the serum of mammary carcinoma patients.
Carcinoma
Gallbladder carcinoma producing alpha-fetoprotein.
Carcinoma
Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, CEA and alpha-fetoprotein.
Carcinoma
Gene expression in poorly differentiated papillary thyroid carcinomas.
Carcinoma
Genome-Wide Association Studies of Autoimmune Thyroid Diseases, Thyroid Function, and Thyroid Cancer.
Carcinoma
H-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma.
Carcinoma
Hepatoid carcinoma of the lung with production of alpha-fetoprotein and abnormal prothrombin: an autopsy case report.
Carcinoma
Hepatoid carcinoma of the ovary without staining for alpha-fetoprotein.
Carcinoma
Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP).
Carcinoma
Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma.
Carcinoma
Human yolk sac carcinoma antigens--a step beyond alpha-fetoprotein.
Carcinoma
Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells.
Carcinoma
Immunocytochemical evaluation of primary human esophageal carcinomas and their xenografts for keratin, beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Carcinoma
Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.
Carcinoma
Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin.
Carcinoma
Immunohistochemical localization of c-mos at the light and electron microscope level in non-small cell lung carcinomas.
Carcinoma
Increasing serum levels of alpha-fetoprotein in a patient with relapsing gallbladder carcinoma.
Carcinoma
Inhibition of mutant Kras(G12D)-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
Carcinoma
K-ras Mutation, HPV Infection and Smoking or Alcohol Abuse Positively Correlate with Esophageal Squamous Carcinoma.
Carcinoma
Lack of B-RAF mutations in head and neck squamous cell carcinoma.
Carcinoma
Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
Carcinoma
Lectin reactivity of alpha-fetoprotein in a case of renal cell carcinoma.
Carcinoma
Loss of heterozygosity at the c-raf locus in small cell lung carcinoma.
Carcinoma
MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas.
Carcinoma
MEKK3 and survivin expression in cervical cancer: association with clinicopathological factors and prognosis.
Carcinoma
MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
Carcinoma
MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
Carcinoma
MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1.
Carcinoma
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
Carcinoma
Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.
Carcinoma
Nanogram per milliliter-level immunologic detection of alpha-fetoprotein with integrated rotating-resonance microcantilevers for early-stage diagnosis of heptocellular carcinoma.
Carcinoma
No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
Carcinoma
Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma.
Carcinoma
Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): a case report.
Carcinoma
Ovarian hepatoid carcinoma without staining for alpha-fetoprotein in the primary site.
Carcinoma
Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma.
Carcinoma
Overexpression of MEKK2 is associated with colorectal carcinogenesis.
Carcinoma
Overexpression of the Tpl-2/Cot oncogene in human breast cancer.
Carcinoma
Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
Carcinoma
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.
Carcinoma
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case.
Carcinoma
Pathological studies on primary carcinoma of the liver. A study of 89 cases among 3890 necropsies and a study of alpha-fetoprotein in the serum of 17 cases.
Carcinoma
pERK activation in esophageal carcinomas: clinicopathological associations.
Carcinoma
Population Pharmacokinetic Analysis of Sorafenib in Patients with Solid Tumors.
Carcinoma
Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.
Carcinoma
Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastases.
Carcinoma
Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis.
Carcinoma
Prostatic adenocarcinoma CNS parenchymal and dural metastases: alterations in ERG, CHD1 and MAP3K7 expression.
Carcinoma
Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Carcinoma
Quantitative analysis of alpha-fetoprotein mRNA in circulating peripheral blood of patients with hepatocellular and alpha-fetoprotein-producing gastric carcinomas.
Carcinoma
Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus.
Carcinoma
Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas.
Carcinoma
Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.
Carcinoma
Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Carcinoma
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Carcinoma
Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Carcinoma
Studies on alpha-fetoprotein produced by renal cell carcinoma.
Carcinoma
The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors.
Carcinoma
The effect of gefitinib on B-RAF mutant non-small cell lung cancer and transfectants.
Carcinoma
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.
Carcinoma
The Expression and Role of MEKK3 in Renal Clear Cell Carcinoma.
Carcinoma
The Influence of Alpha-fetoprotein on Natural Suppressor Cell Activity and Ehrlich Carcinoma Growth.
Carcinoma
The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.
Carcinoma
The use of radioiodinated alpha-fetoprotein for the scintigraphic detection of mouse mammary carcinomas.
Carcinoma
Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.
Carcinoma
Tumor thrombus in the splenic vein originated from gastric carcinoma that produced alpha-fetoprotein.
Carcinoma
Tumorigenesis suppressor pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
Carcinoma
Uptake of radiolabeled alpha-fetoprotein by mouse mammary carcinomas and its usefulness in tumor scintigraphy.
Carcinoma
Well-differentiated gall bladder hepatoid carcinoma producing alpha-fetoprotein: a case report.
Carcinoma
[A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma]
Carcinoma
[A case of clear cell carcinoma of the hepatic bile duct with production of alpha-fetoprotein (AFP)]
Carcinoma
[A case of IgA-lambda producing gastric plasmacytoma associated with alpha-fetoprotein producing gastric carcinoma]
Carcinoma
[A case of renal carcinoma with bone metastasis, producing alpha-fetoprotein]
Carcinoma
[A case of renal cell carcinoma producing alpha-fetoprotein]
Carcinoma
[Adrenal hepatoid carcinoma producing alpha-fetoprotein: a case report]
Carcinoma
[Alpha-fetoprotein and its appearance in primary liver carcinoma]
Carcinoma
[Alpha-fetoprotein in embryonal cell carcinoma of the testis]
Carcinoma
[An alpha-fetoprotein and PIVKA-II producing carcinoma of the colon: report of a case]
Carcinoma
[An autopsied case of alpha-fetoprotein (AFP) producing large cell carcinoma of the lung (author's transl)]
Carcinoma
[An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]
Carcinoma
[An immunohistological study on an autopsy case of duodenal carcinoma associated with marked increasing of alpha-fetoprotein in the serum (author's transl)]
Carcinoma
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]
Carcinoma
[Cytodiagnosis of primary liver cell carcinoma with reference to alpha-fetoprotein (author's transl)]
Carcinoma
[Elevated serum alpha-fetoprotein in a case of rectum carcinoma with liver cirrhosis (author's transl)]
Carcinoma
[Genetic polymorphism and susceptibility to cancer]
Carcinoma
[Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas]
Carcinoma
[On the alpha-fetoprotein in the diagnosis of primary liver carcinoma (author's transl)]
Carcinoma
[Positive alpha-fetoprotein in a case of metastatic gastric carcinoma, Borrmann type 3]
Carcinoma
[Serous genital carcinoma : Molecular pathogenesis and the role of tubal fimbria.]
Carcinoma
[Stage IV renal cell carcinoma producing alpha-fetoprotein treated with multimodal treatment. A case report]
Carcinoma
[The immunohistological study of alpha-fetoprotein on carcinoma of digestive organs (author's transl)]
Carcinoma
[The inhibitory effect of mitomycin C on experimental liver metastasis of alpha-fetoprotein producing human gastric carcinoma induced by intra-splenic transplantation in nude mice]
Carcinoma in Situ
[Serous genital carcinoma : Molecular pathogenesis and the role of tubal fimbria.]
Carcinoma, Acinar Cell
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.
Carcinoma, Acinar Cell
Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein.
Carcinoma, Acinar Cell
Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression.
Carcinoma, Acinar Cell
[Increase of serum alpha-fetoprotein in a patient with acinar cell carcinoma of the pancreas]
Carcinoma, Basal Cell
B-Raf Mutations, Microsatellite Instability and p53 Protein Expression in Sporadic Basal Cell Carcinomas.
Carcinoma, Embryonal
A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft.
Carcinoma, Embryonal
A suprasellar embryonal carcinoma producing alpha-fetoprotein and human chorionic gonadotropin; treated with combined chemotherapy followed by radiotherapy.
Carcinoma, Embryonal
Alpha-fetoprotein and human chorionic gonadotropin in embryonal carcinoma of the ovary. An 8-year survival case.
Carcinoma, Embryonal
Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Carcinoma, Embryonal
Differential expression of protooncogenes in human germ cell tumors of the testis.
Carcinoma, Embryonal
Embryonal carcinoma with falsely positive elevation of serum alpha-fetoprotein after curative therapy: a case report.
Carcinoma, Embryonal
Expression of JNK cascade scaffold protein JSAP1 in the mouse nervous system.
Carcinoma, Embryonal
Immunohistochemistry of alpha-fetoprotein in testicular embryonal carcinoma.
Carcinoma, Embryonal
MEKK4 mediates differentiation in response to retinoic acid via activation of c-Jun N-terminal kinase in rat embryonal carcinoma P19 cells.
Carcinoma, Embryonal
The capacity for differentiation and production of human chorionic gonadotropin and alpha-fetoprotein in human embryonal carcinoma cell lines.
Carcinoma, Embryonal
Tissue-specific activation of a cloned alpha-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line.
Carcinoma, Embryonal
[A case of alpha-fetoprotein producing embryonal carcinoma of the stomach]
Carcinoma, Embryonal
[A case of alpha-fetoprotein producing primary intracranial embryonal carcinoma treated with combination chemotherapy with cis-platinum, vinblastine and bleomycin (author's transl)]
Carcinoma, Embryonal
[Embryonal carcinoma and vitelline tumor of the mediastinum. Diagnostic and prognostic value of alpha-fetoprotein levels. A propos of 5 cases]
Carcinoma, Endometrioid
Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Carcinoma, Endometrioid
Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Carcinoma, Hepatocellular
240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag.
Carcinoma, Hepatocellular
8-Quinolineboronic acid as a potential phosphorescent molecular switch for the determination of alpha-fetoprotein variant for the prediction of primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Carcinoma, Hepatocellular
A comparison between alpha-fetoprotein and p53 antibodies in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
A comparison between des-gamma-carboxy prothrombin and alpha-fetoprotein as markers of hepatocellular carcinoma in southern African blacks.
Carcinoma, Hepatocellular
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis.
Carcinoma, Hepatocellular
A new restriction fragment length polymorphism of the human alpha-fetoprotein gene in Japanese individuals: detection of loss of heterozygosity in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
Carcinoma, Hepatocellular
A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma.
Carcinoma, Hepatocellular
A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Carcinoma, Hepatocellular
A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Carcinoma, Hepatocellular
A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.
Carcinoma, Hepatocellular
A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Carcinoma, Hepatocellular
A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma.
Carcinoma, Hepatocellular
A specific alpha-fetoprotein gene binding protein in alpha-fetoprotein producing rat hepatomas.
Carcinoma, Hepatocellular
Aberrant expression of a fetal glycoprotein 68 in hepatocellular carcinoma: a comparative study on the expression of alpha-fetoprotein and carcinoembryonic antigen.
Carcinoma, Hepatocellular
Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.
Carcinoma, Hepatocellular
Activated c-raf gene in a rat hepatocellular carcinoma induced by 2-amino-3-methylimidazo[4,5-f]quinoline.
Carcinoma, Hepatocellular
Activation of alpha-fetoprotein synthesis in rat hepatoma cells with reduced sensitivity to dexamethasone.
Carcinoma, Hepatocellular
Activation of rat c-raf during transfection of hepatocellular carcinoma DNA.
Carcinoma, Hepatocellular
Acute exacerbation of hepatitis in liver cirrhosis with very high levels of alpha-fetoprotein but no occurrence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Age-distribution of alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Albumin and alpha-fetoprotein gene expression and DNA methylation in rat hepatoma cell lines.
Carcinoma, Hepatocellular
Albumin and alpha-fetoprotein gene transcription in rat hepatoma cell lines is correlated with specific DNA hypomethylation and altered chromatin structure in the 5' region.
Carcinoma, Hepatocellular
Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production.
Carcinoma, Hepatocellular
Allomyrina dichotoma lectin-nonreactive alpha-fetoprotein in hepatocellular carcinoma and other tumors: comparison with Ricinus communis agglutinin-I.
Carcinoma, Hepatocellular
Alpha-fetoprotein (AFP) expression in clones of McA-RH 7777 rat hepatoma: correlation with the occurrence of homogeneously staining regions on chromosome 14.
Carcinoma, Hepatocellular
Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary.
Carcinoma, Hepatocellular
alpha-Fetoprotein (alphaFP) as a marker for hepatoma and yolk sac tumors.
Carcinoma, Hepatocellular
Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
Carcinoma, Hepatocellular
Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.
Carcinoma, Hepatocellular
Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein and albumin produced by subclonal cell population of the ascites hepatoma AH-66 in vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.
Carcinoma, Hepatocellular
Alpha-Fetoprotein and hepatitis B antigen in hepatoma and hepatitis.
Carcinoma, Hepatocellular
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Carcinoma, Hepatocellular
Alpha-fetoprotein and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again.
Carcinoma, Hepatocellular
Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
Carcinoma, Hepatocellular
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Carcinoma, Hepatocellular
Alpha-fetoprotein as an aid for diagnosis of primary hepatoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.
Carcinoma, Hepatocellular
Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes.
Carcinoma, Hepatocellular
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Carcinoma, Hepatocellular
alpha-Fetoprotein detected in rat transplantable hepatomas by radioimmunoassay.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Carcinoma, Hepatocellular
Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein expression in hepatocellular carcinoma: a clinical study.
Carcinoma, Hepatocellular
Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
Carcinoma, Hepatocellular
alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells.
Carcinoma, Hepatocellular
Alpha-fetoprotein glycosylation is abnormal in some hepatocellular carcinoma, including white patients with a normal alpha-fetoprotein concentration.
Carcinoma, Hepatocellular
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Carcinoma, Hepatocellular
Alpha-fetoprotein in bovine hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Carcinoma, Hepatocellular
Alpha-fetoprotein in hepatocellular carcinoma with an abnormal electrophoretic alpha-1-fraction.
Carcinoma, Hepatocellular
Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
Carcinoma, Hepatocellular
Alpha-fetoprotein in monkeys with hepatoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization.
Carcinoma, Hepatocellular
Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in the diagnosis of hepatoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Carcinoma, Hepatocellular
Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib.
Carcinoma, Hepatocellular
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Carcinoma, Hepatocellular
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
Carcinoma, Hepatocellular
Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein levels in normal males from seven ethnic groups with different hepatocellular carcinoma risks.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Carcinoma, Hepatocellular
alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Carcinoma, Hepatocellular
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
Carcinoma, Hepatocellular
Alpha-fetoprotein mRNA: variation of half-life in rat hepatoma cell lines and destabilization by sodium butyrate.
Carcinoma, Hepatocellular
Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.
Carcinoma, Hepatocellular
Alpha-fetoprotein producing clones derived from ascites hepatoma AH70B culture.
Carcinoma, Hepatocellular
Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy.
Carcinoma, Hepatocellular
Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival.
Carcinoma, Hepatocellular
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis.
Carcinoma, Hepatocellular
Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.
Carcinoma, Hepatocellular
alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
alpha-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand.
Carcinoma, Hepatocellular
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the american association for the study of liver diseases.
Carcinoma, Hepatocellular
Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells.
Carcinoma, Hepatocellular
Alpha-Fetoprotein synthesis in cultured cells: studies on Yoshida sarcoma and ascites hepatoma in vitro.
Carcinoma, Hepatocellular
Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Carcinoma, Hepatocellular
Alpha-fetoprotein testing is still necessary for the detection of small hepatocellular carcinomas.
Carcinoma, Hepatocellular
Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Carcinoma, Hepatocellular
alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.
Carcinoma, Hepatocellular
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Alpha-fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.
Carcinoma, Hepatocellular
Alpha-fetoprotein: diagnostic and prognostic use in patients with hepatomas.
Carcinoma, Hepatocellular
Alpha-fetoprotein: its immunofluorescent localization in human fetal liver and hepatoma.
Carcinoma, Hepatocellular
alpha-Fetoprotein: studies of tumor-associated antigen cytotoxicity in mouse hepatoma BW7756.
Carcinoma, Hepatocellular
Alpha-Fetoprotein: The Predictor of Microvascular Invasion in Solitary Small Hepatocellular Carcinoma and Criterion for Anatomic or Non-Anatomic Hepatic Resection.
Carcinoma, Hepatocellular
Altered dynamics of alpha-fetoprotein production following pyridoxine and adenosine 5'-triphosphate administration to cirrhotic patients with or without primary hepatomas and to liver-injured and hepatoma-bearing rats.
Carcinoma, Hepatocellular
Altered glycosylation of alpha-fetoprotein in hepadnavirus-induced hepatocellular carcinoma of the woodchuck.
Carcinoma, Hepatocellular
An analysis of the UNOS liver transplant registry: High serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Carcinoma, Hepatocellular
An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein.
Carcinoma, Hepatocellular
An elevated neutrophil-to-lymphocyte ratio predicts a poor postoperative survival in primary hepatocellular carcinoma patients with a normal preoperative serum level of alpha-fetoprotein.
Carcinoma, Hepatocellular
An immuno-electron microscopic study on intra and extracellular localization of alpha-fetoprotein in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Carcinoma, Hepatocellular
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Carcinoma, Hepatocellular
Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization.
Carcinoma, Hepatocellular
Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Carcinoma, Hepatocellular
Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and alpha-fetoprotein expression status.
Carcinoma, Hepatocellular
Apolipoproteinemia A and alpha-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: several interpretations.
Carcinoma, Hepatocellular
Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
Carcinoma, Hepatocellular
Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4? on hepatocellular carcinoma.
Carcinoma, Hepatocellular
Appearance of alpha-fetoprotein in rat serum during induction of primary hepatoma with regard to development of histological changes in liver tissue.
Carcinoma, Hepatocellular
Application of des-gamma-carboxy prothrombin as a complementary tumor marker with alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Carcinoma, Hepatocellular
Assessment of Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma in Middle Eastern Patients.
Carcinoma, Hepatocellular
Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Carcinoma, Hepatocellular
Author Correction: Alpha-fetoprotein inhibits autophagy to promote malignant behaviour in hepatocellular carcinoma cells by activating PI3K/AKT/mTOR signalling.
Carcinoma, Hepatocellular
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
B-Raf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Biosynthesis of alpha-fetoprotein in cultured hepatoma cells.
Carcinoma, Hepatocellular
c-Ha-ras down regulates the alpha-fetoprotein gene but not the albumin gene in human hepatoma cells.
Carcinoma, Hepatocellular
Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.
Carcinoma, Hepatocellular
Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cell-mediated immune responses to alpha-fetoprotein and other antigens in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Change of alpha-fetoprotein content during cell cycle of human hepatoma cells in vitro: flow cytometric analysis.
Carcinoma, Hepatocellular
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
Carcinoma, Hepatocellular
Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization.
Carcinoma, Hepatocellular
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Carcinoma, Hepatocellular
Characterization of alpha-fetoprotein secreted from cultured reuber H-35 hepatoma cells.
Carcinoma, Hepatocellular
Chromosome analysis of hepatocellular carcinoma 7777 and correlation with alpha-fetoprotein production.
Carcinoma, Hepatocellular
Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein.
Carcinoma, Hepatocellular
Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort.
Carcinoma, Hepatocellular
Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
Carcinoma, Hepatocellular
Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.
Carcinoma, Hepatocellular
Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: Comparison in mice and humans.
Carcinoma, Hepatocellular
Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States.
Carcinoma, Hepatocellular
Clinical evaluation of pancreatitis-associated protein as a serum marker of hepatocellular carcinoma: comparison with alpha-fetoprotein.
Carcinoma, Hepatocellular
Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Carcinoma, Hepatocellular
Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients.
Carcinoma, Hepatocellular
Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II.
Carcinoma, Hepatocellular
Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of Alpha-Fetoprotein mRNA in Peripheral Blood in Liver Resection for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20?ng/mL.
Carcinoma, Hepatocellular
Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.
Carcinoma, Hepatocellular
Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
Carcinoma, Hepatocellular
Clinical utility of simultaneous measurement of alpha-fetoprotein and des-?-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
Carcinoma, Hepatocellular
Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Carcinoma, Hepatocellular
Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combination of alpha-fetoprotein mRNA-based detection of hematogenously disseminating hepatocellular carcinoma cells and analysis of cancer cell membrane fluidity is more accurate in screening patients at risk of postoperative recurrence.
Carcinoma, Hepatocellular
Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Carcinoma, Hepatocellular
Combined analysis of serum alpha-fetoprotein and MAGE-A3-specific cytotoxic T lymphocytes in peripheral blood for diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Carcinoma, Hepatocellular
Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth.
Carcinoma, Hepatocellular
Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study.
Carcinoma, Hepatocellular
Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Carcinoma, Hepatocellular
Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone.
Carcinoma, Hepatocellular
Concanavalin A affinity molecular variants of alpha-fetoprotein in neonatal rat serum and in the serum of rats bearing hepatomas.
Carcinoma, Hepatocellular
Concurrent evaluation of p53, beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Conditions required for activation of the mouse albumin or alpha-fetoprotein gene in hybrids between mouse lymphoblastoma and rat hepatoma cells.
Carcinoma, Hepatocellular
Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Carcinoma, Hepatocellular
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Control of albumin and alpha-fetoprotein expression in rat liver and in some transplantable hepatocellular carcinomas.
Carcinoma, Hepatocellular
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
Carcinoma, Hepatocellular
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Carcinoma, Hepatocellular
Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico.
Carcinoma, Hepatocellular
Correlation between serum level of, and tissue positivity for, alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Corrigendum: Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Carcinoma, Hepatocellular
Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.
Carcinoma, Hepatocellular
CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation.
Carcinoma, Hepatocellular
Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients.
Carcinoma, Hepatocellular
Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells.
Carcinoma, Hepatocellular
Datura stramonium agglutinin-reactive alpha-fetoprotein isoforms in hepatocellular carcinoma and other tumors.
Carcinoma, Hepatocellular
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
Carcinoma, Hepatocellular
Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
Carcinoma, Hepatocellular
Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives.
Carcinoma, Hepatocellular
Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor.
Carcinoma, Hepatocellular
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.
Carcinoma, Hepatocellular
Detection of hepatocellular carcinoma with a new alpha-fetoprotein antibody imaging kit.
Carcinoma, Hepatocellular
Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
Carcinoma, Hepatocellular
Detection of messenger RNAs of alpha-fetoprotein and albumin in a human hepatoma cell line by in situ hybridization.
Carcinoma, Hepatocellular
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use.
Carcinoma, Hepatocellular
Determination of optimum cutoff levels of plasma des-gamma-carboxy prothrombin and serum alpha-fetoprotein for the diagnosis of hepatocellular carcinoma using receiver operating characteristic curves.
Carcinoma, Hepatocellular
Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development of on-chip fully automated immunoassay system "?TASWako i30" to measure the changes in glycosylation profiles of alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.
Carcinoma, Hepatocellular
Dexamethasone inhibition of rat hepatoma growth and alpha-fetoprotein synthesis.
Carcinoma, Hepatocellular
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Carcinoma, Hepatocellular
Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Diagnostic accuracy of osteopontin plus alpha-fetoprotein in the hepatocellular carcinoma: A meta-analysis.
Carcinoma, Hepatocellular
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
Carcinoma, Hepatocellular
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Carcinoma, Hepatocellular
Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
Carcinoma, Hepatocellular
Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Diagnostic significance of estimation of serum apolipoprotein A along with alpha-fetoprotein in alcoholic cirrhosis and hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.
Carcinoma, Hepatocellular
Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Carcinoma, Hepatocellular
Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Carcinoma, Hepatocellular
Differential effects of dimethyl sulfoxide and sodium butyrate on alpha-fetoprotein, albumin, and transferrin production by rat hepatomas in culture.
Carcinoma, Hepatocellular
Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients
Carcinoma, Hepatocellular
Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
Carcinoma, Hepatocellular
Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Differential vascular endothelial growth factor A protein expression between small hepatocellular carcinoma and cirrhosis correlates with serum vascular endothelial growth factor A and alpha-fetoprotein.
Carcinoma, Hepatocellular
Direct Monitoring of Fucosylated Glycopeptides of Alpha-Fetoprotein in Human Serum for Early Hepatocellular Carcinoma by Liquid Chromatography-Tandem Mass Spectrometry with Immunoprecipitation.
Carcinoma, Hepatocellular
Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Carcinoma, Hepatocellular
Diverse efficacy of vaccination therapy using the alpha-fetoprotein gene against mouse hepatocellular carcinoma.
Carcinoma, Hepatocellular
Does the Preoperative Alpha-fetoprotein Predict the recurrence and mortality after Hepatectomy for Hepatocellular Carcinoma without macrovascular invasion in patients with normal liver function?
Carcinoma, Hepatocellular
Dynamics of alpha-fetoprotein production compared to alpha 2-macroglobulin during induction of primary hepatoma with 4-dimethylaminoazobenzene in rats.
Carcinoma, Hepatocellular
Dynamics of serum alpha-fetoprotein during spontaneous hepatocellular carcinoma development in mice.
Carcinoma, Hepatocellular
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study.
Carcinoma, Hepatocellular
Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. A case-report.
Carcinoma, Hepatocellular
Early diagnosis of hepatocellular carcinoma with lectin electrophoresis of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Carcinoma, Hepatocellular
Effect of alpha-fetoprotein and albumin on the uptake of polyunsaturated fatty acids by rat hepatoma cells and fetal rat hepatocytes.
Carcinoma, Hepatocellular
Effect of cross-reactivity of alpha-fetoprotein monoclonal antibody on quantitation of serum AFP and radioimmunodetection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effect of cyclic AMP and related substances on the production of alpha-fetoprotein by ascites hepatoma AH-66 cells in culture.
Carcinoma, Hepatocellular
Effect of phorbol esters and hormones on rat hepatoma cells producing alpha-fetoprotein.
Carcinoma, Hepatocellular
Effect of sodium butyrate on alpha-fetoprotein gene expression in rat hepatoma cells in vitro.
Carcinoma, Hepatocellular
Effect of specific immunotherapy with preimmunization against alpha-fetoprotein on a mouse transplantable hepatoma.
Carcinoma, Hepatocellular
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Effects of alpha-difluoromethyl ornithine on alpha-fetoprotein and albumin secretion in human hepatoma cell line, PLC/PRF/5.
Carcinoma, Hepatocellular
Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Carcinoma, Hepatocellular
Effects of dibutyryl adenosine 3'-5' cyclic monophosphate on the ultrastructure of rat ascites hepatoma cells and on the intracellular localization of alpha-fetoprotein.
Carcinoma, Hepatocellular
Effects of hexamethylene bisacetamide on alpha-fetoprotein, albumin, and transferrin production by two rat hepatoma cell lines.
Carcinoma, Hepatocellular
Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Effects of serum and serum-derived factors on the growth and production of alpha-fetoprotein and albumin by human hepatoma cell lines.
Carcinoma, Hepatocellular
Effects of sodium n-butyrate on alpha-fetoprotein and albumin secretion in the human hepatoma cell line PLC/PRF/5.
Carcinoma, Hepatocellular
Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Carcinoma, Hepatocellular
Elevated expression of A-Raf and FA2H in hepatocellular carcinoma is associated with lipid metabolism dysregulation and cancer progression.
Carcinoma, Hepatocellular
Elevated serum alpha-fetoprotein level of nude mice bearing hepatoma cells by treatment with monoclonal antibodies to alpha-fetoprotein.
Carcinoma, Hepatocellular
Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Carcinoma, Hepatocellular
Elevation of transforming growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Embryo extracts opotherapy reduces alpha-fetoprotein levels in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker.
Carcinoma, Hepatocellular
Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of alpha 1-6 fucosyltransferase and N-acetylglucosaminyltransferases III and V.
Carcinoma, Hepatocellular
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Epidermal growth factor stimulates proliferation of rat hepatoma cells producing alpha-fetoprotein.
Carcinoma, Hepatocellular
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
Carcinoma, Hepatocellular
Erratum to: Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Carcinoma, Hepatocellular
Establishment and characterization of primary canine hepatocellular carcinoma cell lines producing alpha-fetoprotein.
Carcinoma, Hepatocellular
Estimation of leucine aminopeptidase and 5-nucleotidase increases alpha-fetoprotein sensitivity in human hepatocellular carcinoma cases.
Carcinoma, Hepatocellular
Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
Carcinoma, Hepatocellular
Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Carcinoma, Hepatocellular
Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
Carcinoma, Hepatocellular
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience.
Carcinoma, Hepatocellular
Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.
Carcinoma, Hepatocellular
Evaluation of seven different staging systems for alpha-fetoprotein expression in hepatocellular carcinoma after hepatectomy.
Carcinoma, Hepatocellular
Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Carcinoma, Hepatocellular
Evaluation of tumour necrosis factor-alpha, soluble P-selectin, gamma-glutamyl transferase, glutathione S-transferase-pi and alpha-fetoprotein in patients with hepatocellular carcinoma before and during chemotherapy.
Carcinoma, Hepatocellular
Excessive alpha-fetoprotein concentrations in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinomas.
Carcinoma, Hepatocellular
Expression of ?-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Carcinoma, Hepatocellular
Expression of alpha-fetoprotein and albumin genes in a rat hepatoma cell line SY/1/80: evidence for the need of species specific serum factors.
Carcinoma, Hepatocellular
Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Carcinoma, Hepatocellular
Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Carcinoma, Hepatocellular
Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms.
Carcinoma, Hepatocellular
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Favorable alpha-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation.
Carcinoma, Hepatocellular
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Carcinoma, Hepatocellular
Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.
Carcinoma, Hepatocellular
Fucosylated alpha-fetoprotein as marker of early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment.
Carcinoma, Hepatocellular
Fucosylated Fraction of Alpha-fetoprotein as a Serological Marker of Early Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Fucosylated fraction of alpha-fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
Carcinoma, Hepatocellular
Fucosylation of alpha-fetoprotein in hepatocellular carcinomas.
Carcinoma, Hepatocellular
Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma.
Carcinoma, Hepatocellular
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.
Carcinoma, Hepatocellular
Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Carcinoma, Hepatocellular
Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with alpha-fetoprotein promoter and Cre/lox P system.
Carcinoma, Hepatocellular
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Carcinoma, Hepatocellular
Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Carcinoma, Hepatocellular
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Carcinoma, Hepatocellular
Glycogen synthase kinase-3? antagonizes ROS-induced hepatocellular carcinoma cell death through suppression of the apoptosis signal-regulating kinase 1.
Carcinoma, Hepatocellular
Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
Carcinoma, Hepatocellular
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis.
Carcinoma, Hepatocellular
Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Heat shock protein 70 chaperoned alpha-fetoprotein in human hepatocellular carcinoma cell line BEL-7402.
Carcinoma, Hepatocellular
Hepatic inflammatory pseudotumor associated with primary biliary cholangitis and elevated alpha-fetoprotein lectin 3 fraction mimicking hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatic Resection for "BCLC Stage A" Hepatocellular Carcinoma. The Prognostic Role of Alpha-Fetoprotein.
Carcinoma, Hepatocellular
Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2.
Carcinoma, Hepatocellular
Hepatitis B virus, alpha-fetoprotein synthesis, and hepatocellular carcinoma in Zaire.
Carcinoma, Hepatocellular
Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.
Carcinoma, Hepatocellular
Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.
Carcinoma, Hepatocellular
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Carcinoma, Hepatocellular
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Carcinoma, Hepatocellular
Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
Carcinoma, Hepatocellular
Hepatocellular carcinoma: patients with increasing alpha-fetoprotein but no mass on ultrasound.
Carcinoma, Hepatocellular
Hepatocellular carcinoma: relation to alcohol, HB-antigen and alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Carcinoma, Hepatocellular
Hepatocyte growth factor down-regulates the alpha-fetoprotein gene expression in PLC/PRF/5 human hepatoma cells.
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
Carcinoma, Hepatocellular
Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences.
Carcinoma, Hepatocellular
High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Carcinoma, Hepatocellular
High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
High-yield and high-degree purification of human alpha-fetoprotein produced by adaptation of the human hepatoma cell line Hep G2 in a serum-free medium.
Carcinoma, Hepatocellular
Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Carcinoma, Hepatocellular
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.
Carcinoma, Hepatocellular
Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Histopathology and immunohistochemistry of large hepatocellular carcinoma with undetectable or low serum levels of alpha-fetoprotein.
Carcinoma, Hepatocellular
Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium.
Carcinoma, Hepatocellular
Hormonal regulation during secretion of alpha-fetoprotein in hepatoma cells grown in synthetic medium.
Carcinoma, Hepatocellular
Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Carcinoma, Hepatocellular
Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver.
Carcinoma, Hepatocellular
Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Carcinoma, Hepatocellular
Immunoelectronmicroscopic study of alpha-fetoprotein synthesis in hepatoma cells.
Carcinoma, Hepatocellular
Immunohistochemical and affinity electrophoretic studies of alpha-fetoprotein of a patient with hepatocellular carcinoma in the intrathoracic space.
Carcinoma, Hepatocellular
Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunohistochemical detection of alpha-fetoprotein, carcinoembryonic antigen, and ferritin in formalin-paraffin sections from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
Carcinoma, Hepatocellular
Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunolocalization of alpha-fetoprotein and albumin in Morris 7777 hepatoma cells grown in vivo.
Carcinoma, Hepatocellular
Immunoprecipitation assay of alpha-fetoprotein synthesis by cultured mouse hepatoma cells treated with estrogens and glucocorticoids.
Carcinoma, Hepatocellular
Immunoradioautographic study of alpha-fetoprotein in hepatoma cells.
Carcinoma, Hepatocellular
Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.
Carcinoma, Hepatocellular
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection.
Carcinoma, Hepatocellular
Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma.
Carcinoma, Hepatocellular
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.
Carcinoma, Hepatocellular
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV cirrhosis with Normal Alanine Transaminase.
Carcinoma, Hepatocellular
In vitro alpha-fetoprotein synthesis by monkey hepatocellular carcinoma.
Carcinoma, Hepatocellular
In vitro cloning of a rat ascites hepatoma cell line, AH66, with special reference to alpha-fetoprotein synthesis.
Carcinoma, Hepatocellular
Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Carcinoma, Hepatocellular
Increased expression of c-jun gene during spontaneous hepatocarcinogenesis in LEC rats.
Carcinoma, Hepatocellular
Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line.
Carcinoma, Hepatocellular
Increased steady-state levels of alpha-fetoprotein mRNA in hepatocellular carcinoma: an analysis by in situ hybridization.
Carcinoma, Hepatocellular
Inducible protein in rat hepatomas with expression alternative to alpha-fetoprotein.
Carcinoma, Hepatocellular
Induction of apoptosis in human hepatoma cells by alpha-fetoprotein.
Carcinoma, Hepatocellular
Induction of hepatomas secreting large amounts of alpha-fetoprotein.
Carcinoma, Hepatocellular
Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma.
Carcinoma, Hepatocellular
Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: lack of correlation with serum alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Inhibition of alpha-fetoprotein production in a hepatoma cell line by antisense oligonucleotide analogues.
Carcinoma, Hepatocellular
Inhibition of synthesis of alpha-fetoprotein by glucocorticoids in cultured hepatoma cells.
Carcinoma, Hepatocellular
Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells.
Carcinoma, Hepatocellular
Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells.
Carcinoma, Hepatocellular
Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
Carcinoma, Hepatocellular
Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion.
Carcinoma, Hepatocellular
Intracellular alpha-fetoprotein level in cultured ascites hepatoma cells of the rat determined as alpha-fetoprotein-negative.
Carcinoma, Hepatocellular
Intracellular synthesis of alpha-fetoprotein and fibrinogen without secretion by Zajdela rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Carcinoma, Hepatocellular
Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
Carcinoma, Hepatocellular
Is Serum Alpha-Fetoprotein Useful for Predicting Recurrence and Mortality Specific to Hepatocellular Carcinoma After Hepatectomy? A Test Based on Propensity Scores and Competing Risks Analysis.
Carcinoma, Hepatocellular
Isolation and characterization of alpha-fetoprotein from the mouse hepatoma BW7756.
Carcinoma, Hepatocellular
Isolation of alpha-fetoprotein messenger ribonucleic acid from AH-66 ascites hepatoma cells.
Carcinoma, Hepatocellular
JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
Carcinoma, Hepatocellular
Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.
Carcinoma, Hepatocellular
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lens culinaris agglutinin-reactive alpha-fetoprotein as a prognostic marker in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Carcinoma, Hepatocellular
Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection.
Carcinoma, Hepatocellular
Letter: Alpha-fetoprotein in urine of hepatoma patients.
Carcinoma, Hepatocellular
Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule.
Carcinoma, Hepatocellular
Liver transplantation (lt) for hepatocellular carcinoma (hcc): relationship between alpha-fetoprotein (afp) and outcome.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience.
Carcinoma, Hepatocellular
Liver transplantation for hepatocellular carcinoma: alpha-fetoprotein should be included in selection criteria.
Carcinoma, Hepatocellular
Living related donor liver transplantation for preoperative alpha-fetoprotein mRNA-positive patients of hepatocellular carcinoma: description of five cases.
Carcinoma, Hepatocellular
Localization of alpha-fetoprotein synthesis in malignancies other than hepatoma.
Carcinoma, Hepatocellular
Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
Carcinoma, Hepatocellular
Loss of alpha-fetoprotein in rat hepatoma culture cells.
Carcinoma, Hepatocellular
Low alpha-fetoprotein hepatocellular carcinoma.
Carcinoma, Hepatocellular
Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Carcinoma, Hepatocellular
Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b.
Carcinoma, Hepatocellular
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Carcinoma, Hepatocellular
Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Major chromatin changes accompany extinction of alpha-fetoprotein gene in hepatoma x fibroblast hybrids.
Carcinoma, Hepatocellular
MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Carcinoma, Hepatocellular
Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Mass screening of primary hepatocellular carcinoma by alpha-fetoprotein in a rural area of Taiwan--a dried blood spot method.
Carcinoma, Hepatocellular
Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Mechanism of the dexamethasone effect on alpha-fetoprotein gene expression in McA-RH8994 rat hepatoma cells.
Carcinoma, Hepatocellular
Mechanisms of alpha-fetoprotein synthesis in hepatoma cells. Combined electron microscopic immunocytochemistry and autoradiography.
Carcinoma, Hepatocellular
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Carcinoma, Hepatocellular
Methylation of the alpha-fetoprotein gene in isogenic rat hepatoma and liver cell lines.
Carcinoma, Hepatocellular
Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas.
Carcinoma, Hepatocellular
MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1.
Carcinoma, Hepatocellular
Microsatellite alterations in human hepatocellular carcinoma infected with hepatitis B virus: associated with the elevation of serum alpha-fetoprotein.
Carcinoma, Hepatocellular
miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.
Carcinoma, Hepatocellular
miR-630 Overexpression in Hepatocellular Carcinoma Tissues is Positively Correlated with alpha-Fetoprotein.
Carcinoma, Hepatocellular
Mixed lineage kinase 3 (MLK3)-activated p38 MAP kinase mediates transforming growth factor-beta-induced apoptosis in hepatoma cells.
Carcinoma, Hepatocellular
Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Carcinoma, Hepatocellular
Molecular heterogeneity of alpha-fetoprotein secreted by primary and transplantable hepatocellular carcinomas.
Carcinoma, Hepatocellular
Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Molecular mechanisms of extinction of liver-specific functions in mouse hepatoma rat fibroblast hybrids: extinction of alpha-fetoprotein gene.
Carcinoma, Hepatocellular
Monitoring hepatocellular carcinoma by using a monoclonal immunoenzymometric assay for alpha-fetoprotein.
Carcinoma, Hepatocellular
Mouse hepatomas with Ha-ras and B-raf mutations differ in mitogen-activated protein kinase signaling and response to constitutive androstane receptor activation.
Carcinoma, Hepatocellular
Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein.
Carcinoma, Hepatocellular
Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein.
Carcinoma, Hepatocellular
Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy.
Carcinoma, Hepatocellular
Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Carcinoma, Hepatocellular
Nodular transformation of the liver, alpha-fetoprotein, and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Non-invasive diagnostic criteria for hepatocellular carcinoma: the value of contrast washout at imaging and the death of alpha-fetoprotein.
Carcinoma, Hepatocellular
Non-specificity of messenger RNA of alpha-fetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans.
Carcinoma, Hepatocellular
Novel and sensitive enzyme immunoassay (immune-complex-transfer enzyme immunoassay) for alpha-fetoprotein from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Nuclear oncogenes and alpha-fetoprotein gene expression in hepatoma cell lines.
Carcinoma, Hepatocellular
Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.
Carcinoma, Hepatocellular
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Carcinoma, Hepatocellular
Organization of the albumin and alpha-fetoprotein genes in fetal and adult rat tissues, and rat hepatomas.
Carcinoma, Hepatocellular
Osteopontin versus alpha-fetoprotein as a diagnostic marker for hepatocellular carcinoma: a meta-analysis.
Carcinoma, Hepatocellular
Overcoming effect of antibody against rat alpha-fetoprotein (AFP) on the growth of daunorubicin-resistant mutant rat ascites hepatoma cell line AH66.
Carcinoma, Hepatocellular
Pattern analysis of serum alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma in liver cirrhosis.
Carcinoma, Hepatocellular
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature.
Carcinoma, Hepatocellular
Phenotypic variability of cultured rat hepatoma cell population in respect to alpha-fetoprotein synthesis.
Carcinoma, Hepatocellular
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
Carcinoma, Hepatocellular
Population Pharmacokinetic Analysis of Sorafenib in Patients with Solid Tumors.
Carcinoma, Hepatocellular
Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.
Carcinoma, Hepatocellular
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein.
Carcinoma, Hepatocellular
Pre and postoperative changes of alpha-fetoprotein and human chorionic gonadotropin in hepatoma of children.
Carcinoma, Hepatocellular
Prediction of invasive activities in hepatocellular carcinomas with special reference to alpha-fetoprotein and des-gamma-carboxyprothrombin.
Carcinoma, Hepatocellular
Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.
Carcinoma, Hepatocellular
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort.
Carcinoma, Hepatocellular
Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Carcinoma, Hepatocellular
Preliminary observation on human saliva alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.
Carcinoma, Hepatocellular
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Primary hepatoma presenting with central abdominal pain and diagnosed from a raised serum alpha-fetoprotein level.
Carcinoma, Hepatocellular
Proceedings: Serum alpha-fetoprotein and Ga67 citrate uptake in hepatoma.
Carcinoma, Hepatocellular
Production of alpha-fetoprotein and normal serum proteins by xenotransplanted human hepatomas in relation to their growth and morphology.
Carcinoma, Hepatocellular
Production of alpha-fetoprotein by cultured rat ascites hepatoma cells determined in vivo as alpha-fetoprotein-negative.
Carcinoma, Hepatocellular
Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Carcinoma, Hepatocellular
Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Carcinoma, Hepatocellular
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.
Carcinoma, Hepatocellular
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization.
Carcinoma, Hepatocellular
Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.
Carcinoma, Hepatocellular
Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence.
Carcinoma, Hepatocellular
Prognostic Values of alpha-fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II in Hepatitis B Virus-related Hepatocellular Carcinoma: A Prospective Study.
Carcinoma, Hepatocellular
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Carcinoma, Hepatocellular
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin.
Carcinoma, Hepatocellular
Protein arginine N-methyltransferase 1 promotes the proliferation and metastasis of hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein.
Carcinoma, Hepatocellular
Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Carcinoma, Hepatocellular
Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
Carcinoma, Hepatocellular
Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Carcinoma, Hepatocellular
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Carcinoma, Hepatocellular
Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy.
Carcinoma, Hepatocellular
Rat c-raf oncogene is located on chromosome 4 and may be activated by sequences from chromosome 13.
Carcinoma, Hepatocellular
Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.
Carcinoma, Hepatocellular
Reference change value for alpha-fetoprotein and its application in early detection of hepatocellular carcinoma in patients with hepatic disease.
Carcinoma, Hepatocellular
Regulation effect of zinc fingers and homeoboxes 2 on alpha-fetoprotein in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Regulation of albumin and alpha-fetoprotein gene expression by colloid osmotic pressure in human hepatoma cells.
Carcinoma, Hepatocellular
Regulation of alpha-fetoprotein and transferrin synthesis and secretion in mouse hepatoma cells.
Carcinoma, Hepatocellular
Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.
Carcinoma, Hepatocellular
Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
Carcinoma, Hepatocellular
Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.
Carcinoma, Hepatocellular
Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Carcinoma, Hepatocellular
Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
Carcinoma, Hepatocellular
Resection versus Ablation for Alpha-fetoprotein Positive Hepatocellular Carcinoma within the Milan Criteria: A Propensity Score Analysis.
Carcinoma, Hepatocellular
Response of alpha-fetoprotein to chemotherapy in patients with hepatomas.
Carcinoma, Hepatocellular
Response of serum alpha-fetoprotein to entecavir therapy predicts risk for hepatocellular carcinoma in patients with chronic hepatitis B.
Carcinoma, Hepatocellular
Response to Ablation and resection for hepatocellular carcinoma within the Milan criteria and high alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Results of a surgical resection of pulmonary metastasis from hepatocellular carcinoma: prognostic impact of the preoperative serum alpha-fetoprotein level.
Carcinoma, Hepatocellular
Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Carcinoma, Hepatocellular
Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Carcinoma, Hepatocellular
Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
Carcinoma, Hepatocellular
RNA interference may be more potent than antisense RNA in human cancer cell lines.
Carcinoma, Hepatocellular
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
Carcinoma, Hepatocellular
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it?
Carcinoma, Hepatocellular
Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Carcinoma, Hepatocellular
Role of the model for end-stage liver disease and serum alpha-fetoprotein as prognostic predictors for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Selection of patients with hepatocellular carcinoma before liver transplantation: need to combine alpha-fetoprotein with morphology?
Carcinoma, Hepatocellular
Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene.
Carcinoma, Hepatocellular
Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Carcinoma, Hepatocellular
Sequence analysis of the proximal promoter region of the human alpha-fetoprotein gene in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Carcinoma, Hepatocellular
Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos.
Carcinoma, Hepatocellular
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and hepatitis B antigen in subjects with hepatoma in south India.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and hepatocellular carcinoma size.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein and variant alkaline phosphatase in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein concentrations in urban and rural Southern African blacks with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
Carcinoma, Hepatocellular
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in a mouse strain (C3H-Avy fB) with spontaneous hepatocellular carcinomas.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in experimental hepatocellular carcinomas in rats.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein in the relatively early stages of hepatocellular carcinoma and its relationship to gross anatomical types.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein level independently predicts post-transplantation survival in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Carcinoma, Hepatocellular
Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Carcinoma, Hepatocellular
Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Carcinoma, Hepatocellular
Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Carcinoma, Hepatocellular
Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Serum tumor markers in patients with hepatocellular carcinoma: diagnosis of alpha-fetoprotein -low or -negative patients.
Carcinoma, Hepatocellular
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Carcinoma, Hepatocellular
Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection.
Carcinoma, Hepatocellular
Significance of alpha-fetoprotein mRNA level in hepatocellular carcinoma patients treated with radiofrequency ablation.
Carcinoma, Hepatocellular
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cell.
Carcinoma, Hepatocellular
Simultaneous determination of alpha-fetoprotein immune complexes and alpha-fetoprotein concentration in hepatocellular carcinoma using dual-label time-resolved immunofluorometric assays.
Carcinoma, Hepatocellular
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Carcinoma, Hepatocellular
Simultaneous multicentric occurrence of early hepatocellular carcinoma in a patient with persistent alpha-fetoprotein elevation.
Carcinoma, Hepatocellular
Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Carcinoma, Hepatocellular
Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
Carcinoma, Hepatocellular
Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Carcinoma, Hepatocellular
Specific enzyme immunoassay for alpha-fetoprotein from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Specific uptake of alpha-fetoprotein and albumin by rat Morris 7777 hepatoma cells.
Carcinoma, Hepatocellular
Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development.
Carcinoma, Hepatocellular
Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Studies on liver cancer. II. Production of alpha-fetoprotein by experimental hepatoma and its characterization.
Carcinoma, Hepatocellular
Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
Carcinoma, Hepatocellular
Subtle hepatocellular carcinoma: a persisting role for alpha-fetoprotein monitoring in high-risk patients with cirrhosis.
Carcinoma, Hepatocellular
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Carcinoma, Hepatocellular
Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells.
Carcinoma, Hepatocellular
Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
Carcinoma, Hepatocellular
Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Synthesis and secretion of alpha-fetoprotein and acute-phase alpha 2-macroglobulin by Zajdela rat ascites hepatoma.
Carcinoma, Hepatocellular
Synthesis of alpha-fetoprotein by membrane-bound polysomes of rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Synthesis of alpha-fetoprotein by rat ascites hepatoma cells.
Carcinoma, Hepatocellular
Systematic review: the prognostic role of alpha-fetoprotein following liver transplant for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Carcinoma, Hepatocellular
Telomerase inhibition decreases alpha-fetoprotein expression and secretion by hepatocellular carcinoma cell lines: in vitro and in vivo study.
Carcinoma, Hepatocellular
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.
Carcinoma, Hepatocellular
The antagonistic effect of dexamethasone and insulin on alpha-fetoprotein secretion by cultured H4-II-E-C3 cells derived from the Reuber H-35 hepatoma.
Carcinoma, Hepatocellular
The c-jun proto-oncogene down-regulates the rat alpha-fetoprotein promoter in HepG2 hepatoma cells without binding to DNA.
Carcinoma, Hepatocellular
The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Carcinoma, Hepatocellular
The effects of dexamethasone on alpha-fetoprotein and albumin synthesis in cultured hepatoma 7777 cells.
Carcinoma, Hepatocellular
The effects of retinoic acid on the expression of alpha-fetoprotein and albumin genes in rat hepatoma cell lines.
Carcinoma, Hepatocellular
The enzymatic basis for the conversion of nonfucosylated to fucosylated alpha-fetoprotein by acyclic retinoid treatment in human hepatoma cells: activation of alpha1-6 fucosyltransferase.
Carcinoma, Hepatocellular
The fatty acid levels of rat alpha-fetoprotein derived from fetuses, pregnancy and hepatoma sera.
Carcinoma, Hepatocellular
The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes.
Carcinoma, Hepatocellular
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.
Carcinoma, Hepatocellular
The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
Carcinoma, Hepatocellular
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.
Carcinoma, Hepatocellular
The influence of antisera specific for alpha-fetoprotein and mouse serum albumin on the viability and protein synthesis of cultured mouse hepatoma cells.
Carcinoma, Hepatocellular
The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
The mouse alpha-fetoprotein promoter is repressed in HepG2 hepatoma cells by hepatocyte nuclear factor-3 (FOXA).
Carcinoma, Hepatocellular
The postresection alpha-fetoprotein in cirrhotic patients with hepatocellular carcinoma. An independent predictor of outcome.
Carcinoma, Hepatocellular
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Carcinoma, Hepatocellular
The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients.
Carcinoma, Hepatocellular
The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.
Carcinoma, Hepatocellular
The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.
Carcinoma, Hepatocellular
The role of methylation in regulating the expression of the alpha-fetoprotein gene in developing rat liver and hepatoma cell lines.
Carcinoma, Hepatocellular
The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib.
Carcinoma, Hepatocellular
The use of a monoclonal antibody against alpha-fetoprotein for the radioimmunodetection of hepatocellular carcinoma.
Carcinoma, Hepatocellular
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Carcinoma, Hepatocellular
The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
Carcinoma, Hepatocellular
The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Theoretical mechanisms for synthesis of carcinogen-induced embryonic proteins: X. Correlation of the induceability of hepatomas and alpha-fetoprotein gene activity.
Carcinoma, Hepatocellular
Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
Carcinoma, Hepatocellular
Thyroid hormone effect on alpha-fetoprotein and albumin coordinate expression by a human hepatoma cell line.
Carcinoma, Hepatocellular
Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
Carcinoma, Hepatocellular
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
Carcinoma, Hepatocellular
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cells.
Carcinoma, Hepatocellular
Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells.
Carcinoma, Hepatocellular
Transforming growth factor beta 1 differentially regulates alpha-fetoprotein and albumin in HuH-7 human hepatoma cells.
Carcinoma, Hepatocellular
Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.
Carcinoma, Hepatocellular
Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
Carcinoma, Hepatocellular
Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis.
Carcinoma, Hepatocellular
Ultrastructural observation of alpha-fetoprotein producing cells in human hepatocellular carcinoma using immunoperoxidase methods--comparison with fetal liver.
Carcinoma, Hepatocellular
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein.
Carcinoma, Hepatocellular
Unique structure of glycopeptide from alpha-fetoprotein produced in human hepatoma cell line, as determined by 1H-nuclear magnetic resonance spectroscopy.
Carcinoma, Hepatocellular
Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Carcinoma, Hepatocellular
Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Carcinoma, Hepatocellular
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of Alpha-fetoprotein Response in Patients Treated with Sorafenib for Advanced Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
Carcinoma, Hepatocellular
Usefulness of preoperative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with hepatocellular carcinoma after living donor liver transplantation.
Carcinoma, Hepatocellular
Usefulness of simultaneous determination of alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Carcinoma, Hepatocellular
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
Carcinoma, Hepatocellular
Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
Carcinoma, Hepatocellular
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.
Carcinoma, Hepatocellular
Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Very high alpha-fetoprotein in a young man due to concomitant presentation of hepatocellular carcinoma and Sertoli cell testis tumor.
Carcinoma, Hepatocellular
ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines.
Carcinoma, Hepatocellular
[131I-labelled tumor-specific antibodies: a trials to concentrate radioisotoopes specifically in the tumor. II. The binding of 131I-labelled anti-human alpha-fetoprotein antibody to the cultured human hepatoma cells]
Carcinoma, Hepatocellular
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein]
Carcinoma, Hepatocellular
[A study on expression of various oncogenes and tumor-associated genes in LEC rats spontaneously developing hepatitis and hepatoma]
Carcinoma, Hepatocellular
[Alpha-fetoprotein and its fucosylation index in the early diagnosis of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Alpha-fetoprotein synthesis in clonogenic cells of rat hepatoma McA-RH 7777]
Carcinoma, Hepatocellular
[Analysis of clinicopathological features and prognosis between alpha-fetoprotein negative and positive hepatocellular carcinoma patients after R0 radical hepatectomy].
Carcinoma, Hepatocellular
[Antigen showing alternative to alpha-fetoprotein expression in rat hepatomas]
Carcinoma, Hepatocellular
[Application of alpha-fetoprotein determination by radioimmunoassay to the diagnosis of primary hepatoma]
Carcinoma, Hepatocellular
[Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Carcinoembryonic antigen, alpha-fetoprotein and hepatoma alkaline phosphatase in gastric carcinoma]
Carcinoma, Hepatocellular
[Changes in the rhythms of the alpha-fetoprotein content of the blood serum of mice with hepatoma 22A and of tumor cell proliferation depending on the time of cyclophosphane administration]
Carcinoma, Hepatocellular
[Clinical evaluation of alpha-fetoprotein as tumor marker for hepatocellular carcinoma (author's transl)]
Carcinoma, Hepatocellular
[Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Comparison of scintigraphy, CT and serum alpha-fetoprotein in patients with hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma]
Carcinoma, Hepatocellular
[Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]
Carcinoma, Hepatocellular
[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma]
Carcinoma, Hepatocellular
[Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration]
HOME
login
history
all enzymes
BRENDA home
History
2.7.11.25 mitogen-activated protein kinase kinase kinase
more
top
